View All Blog Posts

Biopharmaceutical Associations in Southeast Asia Work Together to Educate About Patient-Centered Policy Solutions

Several national associations representing biopharmaceutical companies today announced the launch of Healthy Innovation to draw attention to unmet medical needs in Southeast Asia and the pro-innovation solutions that can improve patients’ lives in the region.

This collaboration will highlight successful public-private partnerships and case studies and address policies that could undermine innovation and private sector investment.

The associations, including the International Pharmaceutical Manufacturers Group (IPMG), Pharmaceutical Association of Malaysia (PhAMA), Pharmaceutical & Healthcare Association of the Philippines (PHAP) and Singapore Association of Pharmaceutical Industries (SAPI) released the following joint statement on the initiative:

“Southeast Asia is one of the fastest growing and dynamic economic regions in the world. Thanks to treatment breakthroughs and wider health care access, people are living longer, healthier lives, but patients still need greater health care options, faster access to existing treatments and cures and improved resources to deliver care. Healthy Innovation will provide policymakers and stakeholders with the tools to develop pro-innovation solutions.”

 Data shows that life expectancy in Southeast Asia has increased by more than 25% over the past 50 years – from 56 years in 1967 to 71 years in 2016. It is estimated that new treatments accounted for as much as 73% of the increase in life expectancies from 2000-2009. But non-communicable diseases (NCDs) like heart disease, diabetes and cancer threaten patient health and strain local budgets. To continue to see improved health outcomes and combat rising rates of NCDs, countries across Southeast Asia must invest in health and adopt policies that promote innovation and ensure patient access to life-saving treatments and cures.

 Healthy Innovation calls on all stakeholders within the region to commit to investing in health and adopting policies that promote innovation. Please visit to learn more.

Recent Blog Posts

Intellectual Property Accelerates Research and Innovation in Southeast Asia

Intellectual property has enabled unprecedented collaborations to innovate and speed up progress on hundreds of potential COVID-19 treatments, diagnostics and vaccines for the world. As we celebrate World Innovation Day on April 21 and World IP Day on April 26, we are reminded how valuable strong intellectual property laws are to addressing global challenges through innovation.

COVID-19 Shows the Essential Role of Ongoing Health Care Innovation

Great progress had been made in the fight against COVID-19. To date, 32.9% of the world’s population is at least partially vaccinated. Still, the global community has a long way to go before everyone is protected. Continuing to prioritize and support innovation to identify effective treatments, vaccines or boosters, and furthering our understanding of variants, remains critical to the global response.